• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个并非腺苷A2受体的3H-NECA选择性结合位点。

A selective binding site for 3H-NECA that is not an adenosine A2 receptor.

作者信息

Keen M, Kelly E, Nobbs P, MacDermot J

机构信息

Department of Pharmacology, Medical School, University of Birmingham, U.K.

出版信息

Biochem Pharmacol. 1989 Nov 1;38(21):3827-33. doi: 10.1016/0006-2952(89)90592-3.

DOI:10.1016/0006-2952(89)90592-3
PMID:2597174
Abstract

In homogenates of NG108-15 cells, adenosine analogues activate adenylate cyclase with the following order of potency: N-ethylcarboxamidoadenosine (NECA) greater than 2-chloroadenosine greater than N6-(L-phenylisopropyl)-adenosine (PIA) = cyclohexyladenosine = 2-phenylaminoadenosine. Adenosine receptor antagonists inhibit NECA-stimulated adenylate cyclase activity with the order of potency 3-isobutyl-1-methyl-xanthine (IBMX) greater than theophylline greater than caffeine. These data suggest that these ligands act at an adenosine A2 receptor. There is an apparently homogenous population of saturable 3H-NECA binding sites in homogenates of NG108-15 cells. These sites have an affinity for 3H-NECA of approximately 1 microM, and are present at a density of approximately 10 pmol/mg protein. Unlabelled NECA, 2-chloroadenosine, IBMX and theophylline displace 3H-NECA binding, with an order of potency that suggests that the 3H-NECA binding site may represent an adenosine A2 receptor. However, PIA, cyclohexyladenosine and 2-phenylaminoadenosine produce no detectable displacement of 3H-NECA binding at concentrations that produce a maximal stimulation of adenylate cyclase activity. Pretreatment of NG108-15 cells with either NECA or PIA produces a homologous desensitization of subsequent responses to all the adenosine analogues, with no effect on subsequent responses to a prostacyclin receptor agonist or NaF. This suggests that all the adenosine analogues examined activate an adenosine A2 receptor. Therefore, the 3H-NECA site at which PIA is inactive cannot represent this receptor.

摘要

在NG108 - 15细胞匀浆中,腺苷类似物激活腺苷酸环化酶的效力顺序如下:N - 乙基羧酰胺腺苷(NECA)>2 - 氯腺苷>N6 - (L - 苯异丙基)腺苷(PIA)=环己基腺苷 = 2 - 苯氨基腺苷。腺苷受体拮抗剂抑制NECA刺激的腺苷酸环化酶活性的效力顺序为:3 - 异丁基 - 1 - 甲基黄嘌呤(IBMX)>茶碱>咖啡因。这些数据表明这些配体作用于腺苷A2受体。在NG108 - 15细胞匀浆中存在明显同质的可饱和3H - NECA结合位点群体。这些位点对3H - NECA的亲和力约为1微摩尔,且以约10皮摩尔/毫克蛋白质的密度存在。未标记的NECA、2 - 氯腺苷、IBMX和茶碱可取代3H - NECA结合,其效力顺序表明3H - NECA结合位点可能代表腺苷A2受体。然而,PIA、环己基腺苷和2 - 苯氨基腺苷在产生腺苷酸环化酶活性最大刺激的浓度下,对3H - NECA结合没有可检测到的取代作用。用NECA或PIA预处理NG108 - 15细胞会使随后对所有腺苷类似物的反应产生同源脱敏,而对随后对前列环素受体激动剂或NaF的反应没有影响。这表明所检测的所有腺苷类似物均激活腺苷A2受体。因此,PIA无活性的3H - NECA位点不能代表该受体。

相似文献

1
A selective binding site for 3H-NECA that is not an adenosine A2 receptor.一个并非腺苷A2受体的3H-NECA选择性结合位点。
Biochem Pharmacol. 1989 Nov 1;38(21):3827-33. doi: 10.1016/0006-2952(89)90592-3.
2
Ra adenosine receptors in human platelets. Characterization by 5'-N-ethylcarboxamido[3H]adenosine binding in relation to adenylate cyclase activity.人血小板中的Ra腺苷受体。通过5'-N-乙基羧酰胺基[3H]腺苷结合并与腺苷酸环化酶活性相关的特性研究。
Naunyn Schmiedebergs Arch Pharmacol. 1984 Mar;325(3):226-33. doi: 10.1007/BF00495948.
3
Characterization of 5'-N-ethylcarboxamido[3H]adenosine binding to pig aorta smooth muscle membranes.5'-N-乙基羧酰胺基[3H]腺苷与猪主动脉平滑肌膜结合的特性研究
Biochem Pharmacol. 1987 Nov 1;36(21):3621-7. doi: 10.1016/0006-2952(87)90011-6.
4
Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.用[3H]NECA标记的大鼠纹状体膜中A2腺苷受体的特性研究。
Mol Pharmacol. 1986 Apr;29(4):331-46.
5
[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.[3H]CGS 21680,一种选择性A2腺苷受体激动剂,可直接标记大鼠脑中的A2受体。
J Pharmacol Exp Ther. 1989 Dec;251(3):888-93.
6
Identification of A1 and A2 adenosine receptors in the rat spinal cord.大鼠脊髓中A1和A2腺苷受体的鉴定。
J Pharmacol Exp Ther. 1987 Sep;242(3):905-10.
7
Identification of adenosine receptor in rat pineal gland: evidence for A-2 selectivity.
J Neurochem. 1989 Sep;53(3):733-7. doi: 10.1111/j.1471-4159.1989.tb11766.x.
8
Heterogeneity of binding sites for N-ethylcarboxamido[3H]adenosine in rat brain: effects of N-ethylmaleimide.
Brain Res. 1986 Dec 10;399(2):232-9. doi: 10.1016/0006-8993(86)91513-1.
9
Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils.腺苷;人类中性粒细胞超氧阴离子生成的生理调节剂。腺苷通过人类中性粒细胞上的A2受体发挥作用。
J Immunol. 1985 Aug;135(2):1366-71.
10
A1- and A2-purinoceptors in the guinea-pig uterus.
Clin Exp Pharmacol Physiol. 1993 Oct;20(10):609-17. doi: 10.1111/j.1440-1681.1993.tb01642.x.

引用本文的文献

1
A(2A) adenosine receptors in human peripheral blood cells.人类外周血细胞中的A(2A)腺苷受体。
Br J Pharmacol. 2000 Jan;129(1):2-11. doi: 10.1038/sj.bjp.0703045.
2
Study of adenosine A2 receptors in membrane preparations from optic tectum of chicks.雏鸡视顶盖膜制剂中腺苷 A2 受体的研究。
Neurochem Res. 1999 Aug;24(8):1067-74. doi: 10.1023/a:1021017112717.
3
Purification and characterization of an adenotin-like adenosine binding protein from human platelets.从人血小板中纯化和鉴定一种腺嘌呤类似物腺苷结合蛋白
Naunyn Schmiedebergs Arch Pharmacol. 1994 Apr;349(4):374-80. doi: 10.1007/BF00170883.
4
Effects of acute and chronic ethanol on cyclic AMP accumulation in NG108-15 cells: differential dependence of changes on extracellular adenosine.急性和慢性乙醇对NG108-15细胞中环磷酸腺苷积累的影响:变化对细胞外腺苷的差异依赖性。
Br J Pharmacol. 1995 Apr;114(7):1433-41. doi: 10.1111/j.1476-5381.1995.tb13366.x.
5
Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.灵长类动物对奥替米贝(一种前列环素受体的非前列腺素激动剂)的血管反应。
Br J Pharmacol. 1991 Jan;102(1):260-6. doi: 10.1111/j.1476-5381.1991.tb12163.x.
6
Characterization of the human liver vasopressin receptor. Profound differences between human and rat vasopressin-receptor-mediated responses suggest only a minor role for vasopressin in regulating human hepatic function.人肝脏血管加压素受体的特性。人与大鼠血管加压素受体介导的反应之间存在显著差异,这表明血管加压素在调节人类肝脏功能中仅起次要作用。
Biochem J. 1991 May 15;276 ( Pt 1)(Pt 1):189-95. doi: 10.1042/bj2760189.
7
Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.奥替米贝特是一种有效的非前列腺素类血小板聚集抑制剂,通过前列环素受体发挥作用。
Br J Pharmacol. 1991 Jan;102(1):251-9. doi: 10.1111/j.1476-5381.1991.tb12162.x.
8
Concurrent down-regulation of IP prostanoid receptors and the alpha-subunit of the stimulatory guanine-nucleotide-binding protein (Gs) during prolonged exposure of neuroblastoma x glioma cells to prostanoid agonists. Quantification and functional implications.在神经母细胞瘤x胶质瘤细胞长期暴露于前列腺素激动剂期间,IP前列腺素受体和刺激性鸟嘌呤核苷酸结合蛋白(Gs)的α亚基同时下调。定量分析及其功能意义。
Biochem J. 1992 Jul 15;285 ( Pt 2)(Pt 2):529-36. doi: 10.1042/bj2850529.